Tenet Healthcare

Growth in USPI ambulatory volumes and improved revenue-cycle performance (Conifer) will sustain and grow Tenet’s operating cash flow because outpatient procedures have higher throughput and shorter cash conversion than inpatient care. If true, Tenet can fund growth and returns from internally generated cash; if false, capital needs will force asset sales or raise leverage, reducing shareholder optionality.

The large drop in operating income in 2025 reflects transitory items and portfolio changes, and Tenet can restore operating income via cost management, acuity mix optimization and ambulatory growth. Restoring operating_income is necessary for margin normalization and justifying the current valuation; a failure to recover implies structural margin deterioration and multiple compression.

Conifer’s revenue-cycle and value-based services create contractual stickiness and protect revenue and margin conversion because hospitals and health systems are unlikely to switch RCM providers frequently. Persistent Conifer relationships stabilize revenue streams, improve AR days and protect operating margins versus peers that lack integrated RCM.

Tenet’s cash generation and cash balances provide sufficient liquidity to execute ambulatory expansion and selective hospital investment without forcing large equity dilution or distressed asset sales. If cash and operating cash flow remain strong, management can invest in growth and return capital; if liquidity weakens, the company will face constrained growth and potential asset disposals.